lurbinectedin’s role in managing sclc
Published 4 years ago • 2K plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
2:00
dr. west on lurbinectedin in sclc
-
1:28
dr. forster on recent data with lurbinectedin in sclc
-
2:50
dr. farago on effectiveness of single-agent lurbinectedin in sclc
-
1:54
dr. forster on next steps with lurbinectedin in sclc
-
5:46
optimal management of limited-stage sclc
-
5:31
novel therapies in small cell lung cancer (sclc): lurbinectedin
-
3:00
small-cell lung cancer: future directions in care
-
0:50
efficacy and safety of lurbinectedin in elderly patients with relapsed sclc
-
1:05
dr. sabari discusses role of immunotherapy in sclc
-
2:17
small cell lung cancer: future directions in care
-
2:01
palliative radiotherapy with lurbinectedin in patients with extensive stage sclc
-
7:39
data on fda approved therapy for relapsed/refractory sclc
-
4:27
emerging treatment options for sclc
-
0:48
immunotherapy for patients with small-cell lung cancer
-
2:01
findings from atlantis: lurbinectedin/doxorubicin vs topotecan or cav in sclc
-
0:52
luper: lurbinectedin in combination with pembrolizumab in relapsed sclc
-
2:28
lurbinectedin for second line treatment of small cell lung cancer
-
1:28
the role of immunotherapy in sclc
-
1:52
lurbinectedin in combination with pembrolizumab in relapsed sclc